• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Jawboning by HHS Doesn't Scare Insurers

Article

The Department of Health and Human Services isn’t that much of a bully, it turns out.

Health insurers flagged by the department for “unreasonable” premium hikes are refusing to back down in the first year of HHS’s new rate review authority.

Read the full story: http://hcp.lv/JwIJET

Source: Politico

The health reform law gave HHS the power to scrutinize “unreasonable” rate hikes in states that didn’t have robust review programs. But “scrutiny” doesn’t give the department power to actually block the rates from going into effect.

Related Videos
Ted Okon, MBA, of Community Oncology Alliance, during a Zoom video interview
Dr Guru Sonpavde
Takiyah Durham, MBA, and Margaret Larkins-Pettigrew, MD
Steven Coca, DO, MS
Related Content
Acetaminophen Bottle | image credit: luchschenF - stock.adobe.com

Acetaminophen Use Requires Careful Dosing in Patients With SMA, Study Says

December 6th 2023
Article

A non-randomized, open-label, single-site clinical trial evaluated the safety and pharmacokinetics of acetaminophen intake in adults and children with spinal muscular atrophy (SMA) type II.

Read More

Managed Care Cost podcast logo on white background

Managed Care Cast Presents: Insights Into Precision Medicine in NSCLC

November 30th 2023
Podcast

In this podcast, a trio of experts discuss precision medicine in non–small cell lung cancer (NSCLC), current immunotherapies, and more.

Listen

AJAC

Stakeholder Insights on rtCGM in T2D Population Health Management

December 6th 2023
Article

Leading payer and health system stakeholders reviewed literature and shared insights on the value of real-time continuous glucose monitoring (rtCGM) in type 2 diabetes (T2D) population health.

Read More

Managed Care Cast logo

Nathan Walcker Discusses Value-Based Oncology Care Initiatives at FCS

September 8th 2023
Podcast

Nathan Walcker, CEO at Florida Cancer Specialists & Research Institute (FCS), highlights some of the recent partnerships and initiatives at FCS to improve community-based oncology care from a value-based perspective.

Listen

AJMC

Pharmacists and Transitions of Care From Emergency Department to Home

December 6th 2023
Article

Pharmacists’ roles in transitions of care continue to evolve. Evaluation of pharmacist-led interventions as patients transition from emergency department to home is needed.

Read More

Pharmacist getting medication | Image credit: Karanov images - stock.adobe.com

CVS Announces More Transparent Model for Pharmacy Reimbursement, Drug Costs

December 5th 2023
Article

The company is changing the way it prices prescription drugs and providing more transparency, which has been one focus of pharmacy benefit manager regulation efforts.

Read More

© 2023 MJH Life Sciences
AJMC®
All rights reserved.